We crave clinical and scientific data, yet we grieve the performance-based data increasingly directed toward us.
Many patients still insist that I need to check and manage their cholesterol.
For the first time, the federal CMS has made public a database showing what it pays out to individual physicians.
Human beings are unique in the animal kingdom when it comes to nutrition.
The term "personalized medicine" remains an overused promise to apply specific treatment plans.
This higher level of dialysis care in Canada is partly owed to substantially higher reimbursement fees for nephrologists.
When we move from one state to another, typically we must obtain a driver's license from the state to which we are relocating.
As a venue for presenting important research on kidney disease to the world, Kidney Week never disappoints.
After the end of 16-day federal shutdown in October, media headlines touted the financial impact on America and the cost of restarting the government.
Over the past 10 years the annual ESRD incidence rate per million U.S. population has remained stagnant or even shown sporadic downward trends.
For men at risk of developing prostate cancer (PCa), prophylactic prostatectomy seems almost irrational for several reasons
Once again, a study offers evidence that one of the keys to good nutrition is avoiding excess.
In the nephrology community, there have been heightened discussions and apparent enthusiasm about the revival of PD as the prototype for home dialysis.
The vow never to treat SRMs may seem hard to believe and self-defeating.
Two studies presented at the recent NKF Spring Clinical Meetings provide more evidence of a trend toward decreasing use of ESAs and decreasing hemoglobin levels.
Having just returned from the always-stimulating European Association of Urology annual congress, I'd like to share a few impressions.
Almost half a million Americans depend on chronic dialysis therapy to survive.
Physicians are more often defined by their ability to diagnose, treat, and research a disease than their willingness to manage its spectrum of risk.
How often have you met for business in a Starbucks, Coffee Bean, or any other coffee shop?
Kidney Week 2012, held in San Diego, is now history and as usual I like to reflect on the world's biggest and most prestigious meeting for kidney specialists.
Although data suggest that cancer rates are also higher in obese patients, the associations are largely based on observational/population studies.
Historically, foamy urine is considered a warning sign for probable kidney disease.
Cross-sectional imaging now substitutes for physical diagnosis in most emergency rooms.
In recent trips to India, China, Brazil, and other countries, I was intrigued by large numbers of patients with end-stage renal disease who underwent hemodialysis (HD) less frequently than three times a week.
In the past few years, urologists have seen some significant developments related to the treatment of metastatic castration-resistant prostate cancer (CRPC).
Unfortunately, in the past few years, very few studies have looked at issues regarding gender and CKD, and of most concern, looking at response to therapy.
More than 1 million prostate biopsies are performed annually in the United States, predominantly driven by elevations in PSA.
As practicing clinicians in the United States, we generally feel privileged, with access to a highly developed and pioneering medical care system along with an advanced and cutting-edge technology in the world's largest economy.
The March issue features coverage of the 2012 Genitourinary (GU) Cancers Symposium, which was held in San Francisco.
How often do you face with the unpleasant task of waking a sleeping patient during your busy rounds? It happens frequently to many clinicians during their inpatient rounds in the hospital.
The start of 2012 is a good time to look back on the previous year to see the current state of nephrology. What have been the important findings that occurred in the past year, and what do we have to look forward to in the year ahead?
According to current estimates, kidney stones will develop in one in 10 people during their lifetime. This translates into nearly 30 million people in the United States. Clearly, prevention is paramount when dealing with kidney stones.
Individuals, businesses and nations grapple with how to measure success. Are similar productivity measures warranted in medicine?
Renal & Urology News was established in 2002 based on recognition of natural synergies of nephrology and urology. The insight was not immediately intuitive, as care delivery remained largely specialty-based.
Traditional nephrology training makes us believe that it is good practice to start maintenance dialysis therapy sooner rather than later. Nevertheless, recent data indicate that we may encounter yet another "old-practice-was-wrong" paradigm shift.
Incidentally detected renal tumors are increasingly diagnosed in patients with chronic kidney disease.
Nephrologists should rethink the screening level and offer a more conservative and meaningful cutoff level, such as an eGFR of 45.
Practicing nephrologists are frequently consulted to evaluate acute kidney injury (AKI) as inpatient cases.
The role of PSA as a cancer screening tool has recently been evaluated by several large high profile studies with varying interpretations of the data. Regardless of where one stands on the debate, among the clinical dilemmas of PSA-based screening is the negative biopsy conundrum where the reality remains that the best one can offer is, "Good news Mr. Smith, I don't think you have prostate cancer."
The advantages of this emerging specialty are clear to those involved in vascular access care, but some potential downsides must be considered.
The ongoing controversy as to whether premalignant, prostatic lesions are associated with increase risk of developing cancer.
Many Americans harbor fears about the Canadian health care system, and I would like to clear up some misconceptions.
The pending legislation on health care reform can be polarizing, but the motivation supporting it is not.
An international research team have identified a number of families suffering from a mutation in the signal peptide of the renin gene that lead to the development of autosomal dominant CKD.
Who could have guessed that one day physicians would be paid based on the outcomes of patients under their care? This is the imminent reality in nephrology.
One of recent challenges in nephrology and other internal medicine subspecialties is providing care to an increasing number of patients with chronic disease states and wasting syndrome.
Nephrologists propose critical action eGFR thresholds to guide management of kidney disease patients.
In the absence of level I evidence, physician treatment recommendations are subject not only to the objective (interpretations of the cohort literature and practice guidelines) but also the subjective (training patterns, comfort levels, biases and individual experiences).
Overnutrition is a major problem in the general population and a serious risk for metabolic syndrome, cardiovascular disease, and death.
Many nephrologists feel increasingly bewildered by heightened discussion about the upcoming bundling system for dialysis patients. The dialysis industry is a unique and giant enterprise serving nearly a half million Americans with end-stage renal disease (ESRD).